查看购物车
  • Traditional Chinese
  • English
  • Japanese
口腔临床营养市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按适应症、分销渠道、地区和竞争细分
市场调查报告书
商品编码
1331402

口腔临床营养市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按适应症、分销渠道、地区和竞争细分

Oral Clinical Nutrition Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Indication, By Distribution Channel, Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

由于慢性病发病率的上升以及对以患者为中心的护理的日益关注，全球口腔临床营养市场在预测期内将以令人印象深刻的速度增长。此外，营养不良和肌肉减少症和恶病质等相关疾病的日益流行也刺激了对该产品的需求。

更加註重以患者为中心的护理

对以患者为中心的护理的日益关注正在以多种方式影响全球口腔临床营养市场的增长。以患者为中心的护理是一种医疗保健方法，重点是将患者置于护理的中心，并根据他们的个人需求和偏好定制治疗计划。随着患者在医疗保健决策中变得更加知情和有权，这种方法在医疗保健领域变得越来越普遍。

人们越来越关注以患者为中心的护理，这增加了对个性化营养解决方案的需求，强调质量和安全的重要性，并强调对患者教育和支持的需求，从而推动了全球口腔临床营养市场的增长。

以患者为中心的护理正在通过增加对个性化营养解决方案的需求来影响全球口腔临床营养市场的增长。不同医疗状况和营养需求的患者需要不同类型的营养支持。例如，癌症患者可能需要高蛋白、高热量饮食来维持治疗期间的体重和肌肉质量，而糖尿病患者可能需要低糖饮食来控制血糖水平。随着患者对自己的医疗保健越来越了解并需要更加个性化的护理，对可根据其特定营养需求量身定制的口服临床营养产品的需求不断增长。

通过日益重视口腔营养产品的质量和安全性，以患者为中心的护理正在推动口腔临床营养市场的增长。患者越来越意识到与营养不良相关的风险，例如营养不良、脱水和胃肠道并发症。因此，他们需要高质量和安全的口服营养产品来帮助他们保持健康和福祉。对安全有效的口服临床营养产品的需求正在推动行业创新，企业不断开发新的和改进的配方，以满足不同医疗状况患者的需求。

以患者为中心的护理通过提高患者教育和支持的重要性，正在影响全球口腔临床营养市场的增长。接受口服临床营养产品的患者需要接受有关如何正确有效使用这些产品的教育。这包括如何将口服营养产品纳入日常生活、如何准备和服用以及如何监测其营养状况的指导。患者还需要持续的支持和监测，以确保他们实现营养目标并保持健康。因此，对能够为患者提供这种教育和支持的医疗保健专业人员的需求不断增长，这推动了全球口腔临床营养市场的增长。

营养不良和其他相关疾病的患病率增加

营养不良及相关疾病的患病率日益增加是推动全球口腔临床营养市场增长的关键因素之一。营养不良是一种因体内缺乏必需营养素而引起的疾病，可能导致一系列健康问题，包括免疫系统减弱、伤口癒合缓慢以及生长发育受损。营养不良在患有癌症、艾滋病毒/艾滋病和糖尿病等慢性疾病的患者中尤其普遍，因为这些疾病会影响身体吸收和利用营养的能力。

随着全球慢性病发病率持续上升，口服临床营养产品的需求也在不断增加。口服临床营养产品，例如专门的肠内配方和补充剂，旨在提供营养不良或其他相关疾病患者可能无法通过常规饮食获得的必需营养素。

营养不良及相关疾病的日益流行，加上对以患者为中心的护理和创新营养解决方案的日益关注，正在推动全球口腔临床营养市场的增长。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按适应症（阿尔茨海默病、营养缺乏症、癌症护理、慢性肾病、吞嚥困难、其他）
    • 按分销渠道（直接销售与间接销售）
    • 按地区
    • 按公司划分 (2022)
  • 产品图
    • 按指示
    • 按分销渠道
    • 按地区

第 6 章：北美口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按指示
    • 按分销渠道
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按指示
    • 按分销渠道
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按指示
    • 按分销渠道
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按指示
    • 按分销渠道
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲口腔临床营养市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按指示
    • 按分销渠道
    • 按国家/地区
  • MEA：国家分析
    • 南非口腔临床营养
    • 沙特阿拉伯口腔临床营养
    • 阿联酋口腔临床营养

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球口腔临床营养市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Bayer AG
    • Nestle SA
    • GlaxoSmithKline plc.
    • Baxter International Inc.
    • Otsuka Holdings, Co. Ltd.
    • Baxter International Inc.
    • Victus, Inc.
    • Danone SA(Nutricia)

第 16 章：战略建议

简介目录
Product Code: 15208

Global Oral Clinical Nutrition Market is poised to grow at an impressive rate during the forecast period on account of the rising incidence of chronic diseases and an increasing focus on patient-centric care. In addition, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia are also fueling demand for the products.

Increasing demand for products that provide essential nutrients to patients who are unable to consume adequate amounts of food through normal means. This market encompasses a wide range of products, including supplements, enteral feeding formulas, and medical foods, all designed to provide patients with the nutrients they need to support their recovery and maintain their health.

One of the key drivers of the global oral clinical nutrition market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer. These conditions can lead to malnutrition, which in turn can exacerbate the patient's health problems and increase the risk of complications. As a result, healthcare providers are increasingly turning to oral clinical nutrition products to help manage these conditions and improve patient outcomes.

Another key factor driving the oral clinical nutrition market is the aging population. As the population ages, the risk of malnutrition and related conditions increases, as does the need for products that can provide essential nutrients to support overall health and well-being. This has led to a growing demand for oral clinical nutrition products that are specifically designed for elderly patients, such as high-protein supplements and fortified meal replacements.

The market for oral clinical nutrition products is also being driven by a growing focus on patient-centric care. Healthcare providers are increasingly recognizing the importance of personalized nutrition in improving patient outcomes and are turning to oral clinical nutrition products to provide patients with the nutrients they need to support their recovery and maintain their health. This trend is also being driven by the rise of value-based care models, which prioritize patient outcomes and require healthcare providers to take a more holistic approach to patient care.

Oral clinical nutrition products are constantly evolving, with new products being developed and launched to meet the changing needs of patients and healthcare providers. Nestle Health Science launched Peptamen 100 ICU, a high-protein enteral formula specifically designed for critically ill patients, in 2019. The product contains a unique blend of whey and casein proteins, which are rapidly and slowly absorbed, respectively, providing sustained protein delivery to support muscle protein synthesis. Peptamen 100 ICU is also rich in antioxidants, which are essential for supporting the immune system and reducing oxidative stress.

Abbott launched Ensure Max Protein in 2020, a high-protein oral nutritional supplement designed to support muscle health and recovery. The product contains 30 grams of protein per serving, along with essential nutrients such as vitamins and minerals. It is available in three flavors and is designed for use as a snack or meal replacement.

Danone launched Nutricia Age Care in 2021, a range of specialized oral clinical nutrition products designed to meet the unique nutritional needs of elderly patients. The range includes products such as Fortimel Energy, a high-protein oral nutritional supplement, and FortiCare, a specialized enteral formula designed to support wound healing and recovery.

Patient compliance, cost, adverse effects, product availability, and nutritional adequacy are the factors that will hamper the growth of global oral clinical nutrition market in the forecast period.

One of the biggest challenges in global oral clinical nutrition market is patient compliance. Patients may find it difficult to adhere to strict dietary regimens or may have difficulty swallowing or digesting certain products. This can lead to inadequate nutrient intake and reduced effectiveness of the intervention. Healthcare providers must work closely with patients to ensure that they understand the importance of oral clinical nutrition and are able to comply with the prescribed treatment plan. Another challenge is the cost. These products can be expensive, and insurance coverage may be limited or nonexistent. This can make it difficult for patients to obtain the necessary products, especially if they require long-term use. Healthcare providers must work with patients and their families to explore options for financial assistance and insurance coverage.

Increasing Focus on Patient-Centric Care

The increasing focus on patient-centric care is influencing the growth of the global oral clinical nutrition market in several ways. Patient-centric care is a healthcare approach that focuses on putting the patient at the center of care and tailoring treatment plans to their individual needs and preferences. This approach is becoming more prevalent in healthcare as patients are becoming more informed and empowered in their healthcare decision-making.

The increasing focus on patient-centric care is driving the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions, emphasizing the importance of quality and safety, and highlighting the need for patient education and support.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions. Patients with different medical conditions and nutritional needs require different types of nutritional support. For example, a patient with cancer may require a high-protein, high-calorie diet to maintain their weight and muscle mass during treatment, while a patient with diabetes may require a low-sugar diet to control their blood sugar levels. As patients become more informed about their healthcare and demand more personalized care, there is a growing need for oral clinical nutrition products that can be tailored to their specific nutritional needs.

Patient-centric care is driving the growth of the oral clinical nutrition market by increasing the emphasis on the quality and safety of oral nutrition products. Patients are becoming more aware of the risks associated with poor nutrition, such as malnutrition, dehydration, and gastrointestinal complications. As a result, they are demanding high-quality and safe oral nutrition products that can help them maintain their health and well-being. This demand for safe and effective oral clinical nutrition products is driving innovation in the industry, with companies developing new and improved formulations that meet the needs of patients with different medical conditions.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the importance of patient education and support. Patients who receive oral clinical nutrition products need to be educated on how to use them correctly and effectively. This includes guidance on how to incorporate oral nutrition products into their daily routine, how to prepare and administer them, and how to monitor their nutritional status. Patients also require ongoing support and monitoring to ensure that they are achieving their nutritional goals and maintaining their health. As a result, there is a growing need for healthcare professionals who can provide this education and support to patients, which is driving the growth of the global oral clinical nutrition market.

Increasing Prevalence of Malnutrition and other related diseases

The increasing prevalence of malnutrition and related diseases is one of the key factors driving the growth of the global oral clinical nutrition market. Malnutrition is a condition caused by a lack of essential nutrients in the body, which can lead to a range of health problems, including weakened immune systems, slower wound healing, and impaired growth and development. Malnutrition is particularly prevalent in patients with chronic diseases, such as cancer, HIV/AIDS, and diabetes, as these conditions can affect the body's ability to absorb and utilize nutrients.

As the incidence of chronic diseases continues to rise globally, the demand for oral clinical nutrition products is increasing as well. Oral clinical nutrition products, such as specialized enteral formulas and supplements, are designed to provide the essential nutrients that patients with malnutrition or other related diseases may not be able to obtain through their regular diet.

The increasing prevalence of malnutrition and related diseases, coupled with a growing focus on patient-centric care and the availability of innovative nutrition solutions, is driving the growth of the global oral clinical nutrition market.

Market Segmentation

Global Oral Clinical Nutrition Market can be segmented by indication, distribution channel, region, and competitive landscape. Based on indication, the market can be divided into Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, and Others. Based on distribution channels, the market is divided into Direct Sales and Indirect Sales. Regionally, the Oral Clinical Nutrition market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Abbott Laboratories, Inc., Pfizer, Inc., Bayer AG, Nestle SA, GlaxoSmithKline plc., Baxter International Inc., Otsuka Holdings, Co. Ltd., Baxter International Inc., Victus, Inc., Danone SA(Nutricia), are some of the leading players operating in the Global Oral Clinical Nutrition Market.

Report Scope:

In this report, Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Oral Clinical Nutrition Market, By Indication:

  • Alzheimer's
  • Nutritional Deficiencies
  • Cancer Care
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Oral Clinical Nutrition Market, By Distribution Channel:

  • Direct Sales
  • Indirect Sales

Oral Clinical Nutrition Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Oral Clinical Nutrition Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
    • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Indication
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Oral Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Oral Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Oral Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Oral Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oral Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Oral Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Distribution Channel

9. South America Oral Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oral Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Oral Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Oral Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Oral Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oral Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Oral Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Abbott Laboratories, Inc.
    • 15.5.2. Pfizer, Inc.
    • 15.5.3. Bayer AG
    • 15.5.4. Nestle SA
    • 15.5.5. GlaxoSmithKline plc.
    • 15.5.6. Baxter International Inc.
    • 15.5.7. Otsuka Holdings, Co. Ltd.
    • 15.5.8. Baxter International Inc.
    • 15.5.9. Victus, Inc.
    • 15.5.10. Danone SA(Nutricia)

16. Strategic Recommendations